Back
Garmin Vs. Akero Therapeutics Industry Stock Comparison
Buy
55
GRMN
Garmin
Last Price:
$204.99
Seasonality Move:
4.95%
Buy
66
AKRO
Akero Therapeutics
Last Price:
$53.04
Seasonality Move:
22.68%
Buy
66
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $51.61. The Score for AKRO is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $51.61Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
GRMN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.89 | Buy |
Relative Strength Index (14 RSI): | 56.93 | Buy |
Chaikin Money Flow: | 448089 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (191.66 - 204.78) | Buy |
Bollinger Bands (100): | (194.47 - 220.21) | Sell |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.33 | Buy |
Relative Strength Index (14 RSI): | 66.44 | Buy |
Chaikin Money Flow: | 1247197 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.47 - 48.31) | Buy |
Bollinger Bands (100): | (33.84 - 50.78) | Buy |
GRMN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 202.86 | Buy |
20-day SMA: | 199.79 | Buy |
50-day SMA: | 198.22 | Buy |
200-day SMA: | 198.52 | Buy |
8-day EMA: | 202.92 | Buy |
20-day EMA: | 200.78 | Buy |
50-day EMA: | 200.88 | Buy |
200-day EMA: | 194.56 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.33 | Buy |
20-day SMA: | 44.3 | Buy |
50-day SMA: | 41.92 | Buy |
200-day SMA: | 35.63 | Buy |
8-day EMA: | 48.44 | Buy |
20-day EMA: | 45.65 | Buy |
50-day EMA: | 43.4 | Buy |
200-day EMA: | 37.27 | Buy |
Garmin Earnings Growth & GRMN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.52 per share, an increase next quarter of $0.08 per share, an increase this year of $0.92 per share, and an increase next year of $0.65 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and a decrease next year of $0.63 per share.
Garmin Technical Analysis
May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |